Better Donor Transport - Organ Care System FDA Pivotal Trial
Monday, April 21, 2014 - 11:20
in Health & Medicine
At the International Society for Heart and Lung Transplantation (ISHLT) 34th Annual Meeting in San Diego, TransMedics announced results of the PROCEED II heart transplant Food and Drug Administration (FDA) pivotal trial results using the Organ Care System (OCS™) platform.PROCEED II Trial is a large international, multi-center, clinical trial designed to evaluate the ability of the OCS Heart Technology to preserve donor hearts compared with cold storage. read more